|
|
|
|
Real-World Effectiveness of Cabotegravir +
Rilpivirine vs Standard of Care Oral Regimens in the US in OPERA Cohort
|
|
|
CROI 2024 March 3-6 Denver
Ricky K. Hsu, Michael Sension, Jennifer S. Fusco, Laurence Brunet, Quateka Cochran, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Michael B. Wohlfeiler, Brooke Levis, Gregory P. Fusco
|
|
|
|
|
|
|